Chemed Management

Management criteria checks 3/4

Chemed's CEO is Kevin McNamara, appointed in Aug 1994, has a tenure of 29.75 years. total yearly compensation is $12.63M, comprised of 12.7% salary and 87.3% bonuses, including company stock and options. directly owns 0.75% of the company’s shares, worth $63.73M. The average tenure of the management team and the board of directors is 24 years and 15 years respectively.

Key information

Kevin McNamara

Chief executive officer

US$12.6m

Total compensation

CEO salary percentage12.7%
CEO tenure29.8yrs
CEO ownership0.7%
Management average tenure24yrs
Board average tenure15yrs

Recent management updates

Recent updates

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30
The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01
Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07
Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05
Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17
Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01
Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16
Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16
A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Chemed declares $0.38 dividend

Aug 05

Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range

Jul 27

Is Chemed (NYSE:CHE) A Risky Investment?

Jun 29
Is Chemed (NYSE:CHE) A Risky Investment?

Chemed announces a five-year $550M amended and restated senior secured credit facility

Jun 29

Returns on Capital Paint A Bright Future For Chemed (NYSE:CHE)

Jun 14
Returns on Capital Paint A Bright Future For Chemed (NYSE:CHE)

Estimating The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

May 14
Estimating The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Is Chemed (NYSE:CHE) Using Too Much Debt?

Mar 25
Is Chemed (NYSE:CHE) Using Too Much Debt?

CEO Compensation Analysis

How has Kevin McNamara's remuneration changed compared to Chemed's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

US$283m

Dec 31 2023US$13mUS$2m

US$273m

Sep 30 2023n/an/a

US$245m

Jun 30 2023n/an/a

US$226m

Mar 31 2023n/an/a

US$240m

Dec 31 2022US$12mUS$1m

US$250m

Sep 30 2022n/an/a

US$262m

Jun 30 2022n/an/a

US$277m

Mar 31 2022n/an/a

US$267m

Dec 31 2021US$12mUS$1m

US$269m

Sep 30 2021n/an/a

US$308m

Jun 30 2021n/an/a

US$303m

Mar 31 2021n/an/a

US$329m

Dec 31 2020US$12mUS$1m

US$319m

Sep 30 2020n/an/a

US$271m

Jun 30 2020n/an/a

US$263m

Mar 31 2020n/an/a

US$231m

Dec 31 2019US$10mUS$1m

US$220m

Sep 30 2019n/an/a

US$209m

Jun 30 2019n/an/a

US$201m

Mar 31 2019n/an/a

US$205m

Dec 31 2018US$9mUS$1m

US$206m

Sep 30 2018n/an/a

US$206m

Jun 30 2018n/an/a

US$190m

Mar 31 2018n/an/a

US$113m

Dec 31 2017US$8mUS$1m

US$98m

Compensation vs Market: Kevin's total compensation ($USD12.63M) is above average for companies of similar size in the US market ($USD8.43M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


CEO

Kevin McNamara (69 yo)

29.8yrs

Tenure

US$12,625,106

Compensation

Mr. Kevin J. McNamara has been the Chief Executive Officer of Chemed Corporation since May 2001 and has been its President since August 2, 1994. Previously, Mr. McNamara served as an Executive Vice Preside...


Leadership Team

NamePositionTenureCompensationOwnership
Kevin McNamara
CEO, President & Director29.8yrsUS$12.63m0.75%
$ 63.7m
Michael Witzeman
VP, Controller12yrsUS$2.93m0.019%
$ 1.6m
Spencer Lee
Executive Vice President24yrsUS$3.37m0.18%
$ 15.1m
Thomas Hutton
VP & Director36.3yrsno data0.58%
$ 49.7m
Nicholas Westfall
Executive Vice President7.9yrsUS$4.71m0.054%
$ 4.6m
Lisa Reinhard
VP, Chief Administrative Officer & Secretary29.5yrsno datano data
Sherri Warner
Director of Investor Relationsno datano datano data
Brian Judkins
VP, Secretary & Chief Legal Officer3.8yrsno data0.0094%
$ 801.8k

24.0yrs

Average Tenure

59.5yo

Average Age

Experienced Management: CHE's management team is seasoned and experienced (24 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kevin McNamara
CEO, President & Director37.3yrsUS$12.63m0.75%
$ 63.7m
Thomas Hutton
VP & Director39.3yrsno data0.58%
$ 49.7m
Thomas Rice
Independent Director15yrsUS$278.27k0.038%
$ 3.2m
Sandra Laney
Director Emeritus15yrsUS$157.02kno data
Patrick Grace
Independent Director28.3yrsUS$261.52k0.022%
$ 1.8m
George Walsh
Independent Chairman29.3yrsUS$391.02k0.022%
$ 1.9m
Andrea Lindell
Independent Director16yrsUS$272.77k0.041%
$ 3.5m
Christopher Heaney
Independent Director4yrsUS$279.43k0.012%
$ 1.0m
Ron DeLyons
Independent Director4yrsUS$234.52k0.0073%
$ 623.4k
John Mount
Independent Director1.8yrsUS$278.27k0.0024%
$ 208.4k
Eileen McCarthy
Independent Directorless than a yearUS$238.52k0.0019%
$ 165.7k

15.0yrs

Average Tenure

69yo

Average Age

Experienced Board: CHE's board of directors are seasoned and experienced ( 15 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.